Lestaurtinib inhibits JAK2, FLT3, and TrkA with IC50s of 0.9, 3, and less than 25 nM, respectively. Lestaurtinib is a multi-kinase inhibitor. It also has effective activity against the Trk family of receptor tyrosine kinases.
The global Lestaurtinib market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Lestaurtinib is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Lestaurtinib is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Lestaurtinib include Bio-Techne, Cayman Chemical, APExBIO Technology, Abcam, BioVision, Merck, Selleck Chemicals, BOC Sciences and TargetMol, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lestaurtinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lestaurtinib.
The Lestaurtinib market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Lestaurtinib market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lestaurtinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Bio-Techne
Cayman Chemical
APExBIO Technology
Abcam
BioVision
Merck
Selleck Chemicals
BOC Sciences
TargetMol
MyBiosource
Creative Enzymes
Focus Biomolecules
Hello Bio
Santa Cruz Biotechnology
Biorbyt
StressMarq Biosciences
BioCrick BioTech
Clearsynth
Segment by Type
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Segment by Application
Research
Medical
Production by Region
North America
Europe
China
Japan
Taiwan,China
India
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lestaurtinib manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Lestaurtinib by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Lestaurtinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Lestaurtinib Market Overview
1.1 Product Definition
1.2 Lestaurtinib Segment by Type
1.2.1 Global Lestaurtinib Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Min Purity Less Than 98%
1.2.3 Min Purity 98%-99%
1.2.4 Min Purity More Than 99%
1.3 Lestaurtinib Segment by Application
1.3.1 Global Lestaurtinib Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Research
1.3.3 Medical
1.4 Global Market Growth Prospects
1.4.1 Global Lestaurtinib Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Lestaurtinib Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Lestaurtinib Production Estimates and Forecasts (2018-2029)
1.4.4 Global Lestaurtinib Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Lestaurtinib Production Market Share by Manufacturers (2018-2023)
2.2 Global Lestaurtinib Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Lestaurtinib, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Lestaurtinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Lestaurtinib Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Lestaurtinib, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Lestaurtinib, Product Offered and Application
2.8 Global Key Manufacturers of Lestaurtinib, Date of Enter into This Industry
2.9 Lestaurtinib Market Competitive Situation and Trends
2.9.1 Lestaurtinib Market Concentration Rate
2.9.2 Global 5 and 10 Largest Lestaurtinib Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Lestaurtinib Production by Region
3.1 Global Lestaurtinib Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Lestaurtinib Production Value by Region (2018-2029)
3.2.1 Global Lestaurtinib Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Lestaurtinib by Region (2024-2029)
3.3 Global Lestaurtinib Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Lestaurtinib Production by Region (2018-2029)
3.4.1 Global Lestaurtinib Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Lestaurtinib by Region (2024-2029)
3.5 Global Lestaurtinib Market Price Analysis by Region (2018-2023)
3.6 Global Lestaurtinib Production and Value, Year-over-Year Growth
3.6.1 North America Lestaurtinib Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Lestaurtinib Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Lestaurtinib Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Lestaurtinib Production Value Estimates and Forecasts (2018-2029)
3.6.5 Taiwan,China Lestaurtinib Production Value Estimates and Forecasts (2018-2029)
3.6.6 India Lestaurtinib Production Value Estimates and Forecasts (2018-2029)
4 Lestaurtinib Consumption by Region
4.1 Global Lestaurtinib Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Lestaurtinib Consumption by Region (2018-2029)
4.2.1 Global Lestaurtinib Consumption by Region (2018-2023)
4.2.2 Global Lestaurtinib Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Lestaurtinib Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Lestaurtinib Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Lestaurtinib Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Lestaurtinib Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Lestaurtinib Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Lestaurtinib Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Lestaurtinib Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Lestaurtinib Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Lestaurtinib Production by Type (2018-2029)
5.1.1 Global Lestaurtinib Production by Type (2018-2023)
5.1.2 Global Lestaurtinib Production by Type (2024-2029)
5.1.3 Global Lestaurtinib Production Market Share by Type (2018-2029)
5.2 Global Lestaurtinib Production Value by Type (2018-2029)
5.2.1 Global Lestaurtinib Production Value by Type (2018-2023)
5.2.2 Global Lestaurtinib Production Value by Type (2024-2029)
5.2.3 Global Lestaurtinib Production Value Market Share by Type (2018-2029)
5.3 Global Lestaurtinib Price by Type (2018-2029)
6 Segment by Application
6.1 Global Lestaurtinib Production by Application (2018-2029)
6.1.1 Global Lestaurtinib Production by Application (2018-2023)
6.1.2 Global Lestaurtinib Production by Application (2024-2029)
6.1.3 Global Lestaurtinib Production Market Share by Application (2018-2029)
6.2 Global Lestaurtinib Production Value by Application (2018-2029)
6.2.1 Global Lestaurtinib Production Value by Application (2018-2023)
6.2.2 Global Lestaurtinib Production Value by Application (2024-2029)
6.2.3 Global Lestaurtinib Production Value Market Share by Application (2018-2029)
6.3 Global Lestaurtinib Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Bio-Techne
7.1.1 Bio-Techne Lestaurtinib Corporation Information
7.1.2 Bio-Techne Lestaurtinib Product Portfolio
7.1.3 Bio-Techne Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Bio-Techne Main Business and Markets Served
7.1.5 Bio-Techne Recent Developments/Updates
7.2 Cayman Chemical
7.2.1 Cayman Chemical Lestaurtinib Corporation Information
7.2.2 Cayman Chemical Lestaurtinib Product Portfolio
7.2.3 Cayman Chemical Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Cayman Chemical Main Business and Markets Served
7.2.5 Cayman Chemical Recent Developments/Updates
7.3 APExBIO Technology
7.3.1 APExBIO Technology Lestaurtinib Corporation Information
7.3.2 APExBIO Technology Lestaurtinib Product Portfolio
7.3.3 APExBIO Technology Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.3.4 APExBIO Technology Main Business and Markets Served
7.3.5 APExBIO Technology Recent Developments/Updates
7.4 Abcam
7.4.1 Abcam Lestaurtinib Corporation Information
7.4.2 Abcam Lestaurtinib Product Portfolio
7.4.3 Abcam Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Abcam Main Business and Markets Served
7.4.5 Abcam Recent Developments/Updates
7.5 BioVision
7.5.1 BioVision Lestaurtinib Corporation Information
7.5.2 BioVision Lestaurtinib Product Portfolio
7.5.3 BioVision Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.5.4 BioVision Main Business and Markets Served
7.5.5 BioVision Recent Developments/Updates
7.6 Merck
7.6.1 Merck Lestaurtinib Corporation Information
7.6.2 Merck Lestaurtinib Product Portfolio
7.6.3 Merck Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Merck Main Business and Markets Served
7.6.5 Merck Recent Developments/Updates
7.7 Selleck Chemicals
7.7.1 Selleck Chemicals Lestaurtinib Corporation Information
7.7.2 Selleck Chemicals Lestaurtinib Product Portfolio
7.7.3 Selleck Chemicals Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Selleck Chemicals Main Business and Markets Served
7.7.5 Selleck Chemicals Recent Developments/Updates
7.8 BOC Sciences
7.8.1 BOC Sciences Lestaurtinib Corporation Information
7.8.2 BOC Sciences Lestaurtinib Product Portfolio
7.8.3 BOC Sciences Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.8.4 BOC Sciences Main Business and Markets Served
7.7.5 BOC Sciences Recent Developments/Updates
7.9 TargetMol
7.9.1 TargetMol Lestaurtinib Corporation Information
7.9.2 TargetMol Lestaurtinib Product Portfolio
7.9.3 TargetMol Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.9.4 TargetMol Main Business and Markets Served
7.9.5 TargetMol Recent Developments/Updates
7.10 MyBiosource
7.10.1 MyBiosource Lestaurtinib Corporation Information
7.10.2 MyBiosource Lestaurtinib Product Portfolio
7.10.3 MyBiosource Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.10.4 MyBiosource Main Business and Markets Served
7.10.5 MyBiosource Recent Developments/Updates
7.11 Creative Enzymes
7.11.1 Creative Enzymes Lestaurtinib Corporation Information
7.11.2 Creative Enzymes Lestaurtinib Product Portfolio
7.11.3 Creative Enzymes Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Creative Enzymes Main Business and Markets Served
7.11.5 Creative Enzymes Recent Developments/Updates
7.12 Focus Biomolecules
7.12.1 Focus Biomolecules Lestaurtinib Corporation Information
7.12.2 Focus Biomolecules Lestaurtinib Product Portfolio
7.12.3 Focus Biomolecules Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.12.4 Focus Biomolecules Main Business and Markets Served
7.12.5 Focus Biomolecules Recent Developments/Updates
7.13 Hello Bio
7.13.1 Hello Bio Lestaurtinib Corporation Information
7.13.2 Hello Bio Lestaurtinib Product Portfolio
7.13.3 Hello Bio Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.13.4 Hello Bio Main Business and Markets Served
7.13.5 Hello Bio Recent Developments/Updates
7.14 Santa Cruz Biotechnology
7.14.1 Santa Cruz Biotechnology Lestaurtinib Corporation Information
7.14.2 Santa Cruz Biotechnology Lestaurtinib Product Portfolio
7.14.3 Santa Cruz Biotechnology Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.14.4 Santa Cruz Biotechnology Main Business and Markets Served
7.14.5 Santa Cruz Biotechnology Recent Developments/Updates
7.15 Biorbyt
7.15.1 Biorbyt Lestaurtinib Corporation Information
7.15.2 Biorbyt Lestaurtinib Product Portfolio
7.15.3 Biorbyt Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.15.4 Biorbyt Main Business and Markets Served
7.15.5 Biorbyt Recent Developments/Updates
7.16 StressMarq Biosciences
7.16.1 StressMarq Biosciences Lestaurtinib Corporation Information
7.16.2 StressMarq Biosciences Lestaurtinib Product Portfolio
7.16.3 StressMarq Biosciences Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.16.4 StressMarq Biosciences Main Business and Markets Served
7.16.5 StressMarq Biosciences Recent Developments/Updates
7.17 BioCrick BioTech
7.17.1 BioCrick BioTech Lestaurtinib Corporation Information
7.17.2 BioCrick BioTech Lestaurtinib Product Portfolio
7.17.3 BioCrick BioTech Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.17.4 BioCrick BioTech Main Business and Markets Served
7.17.5 BioCrick BioTech Recent Developments/Updates
7.18 Clearsynth
7.18.1 Clearsynth Lestaurtinib Corporation Information
7.18.2 Clearsynth Lestaurtinib Product Portfolio
7.18.3 Clearsynth Lestaurtinib Production, Value, Price and Gross Margin (2018-2023)
7.18.4 Clearsynth Main Business and Markets Served
7.18.5 Clearsynth Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Lestaurtinib Industry Chain Analysis
8.2 Lestaurtinib Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Lestaurtinib Production Mode & Process
8.4 Lestaurtinib Sales and Marketing
8.4.1 Lestaurtinib Sales Channels
8.4.2 Lestaurtinib Distributors
8.5 Lestaurtinib Customers
9 Lestaurtinib Market Dynamics
9.1 Lestaurtinib Industry Trends
9.2 Lestaurtinib Market Drivers
9.3 Lestaurtinib Market Challenges
9.4 Lestaurtinib Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Bio-Techne
Cayman Chemical
APExBIO Technology
Abcam
BioVision
Merck
Selleck Chemicals
BOC Sciences
TargetMol
MyBiosource
Creative Enzymes
Focus Biomolecules
Hello Bio
Santa Cruz Biotechnology
Biorbyt
StressMarq Biosciences
BioCrick BioTech
Clearsynth
听
听
*If Applicable.
